TYP-1-DIABETES - MOGLICHKEITEN DER PRAVENTION

R. Schwertner; W. Rabl; A. G. Ziegler

TYP-1-DIABETES - MOGLICHKEITEN DER PRAVENTION

R. Schwertner
, W. Rabl
, A. G. Ziegler

Klinik und Poliklinik für Kinder- und Jugendmedizin

Technische Universität München

Publikation: Beitrag in Fachzeitschrift › Kurzer Abriss › Begutachtung

Abstract

Type-1-diabetes, being the end-result of an autoimmune disease, can today be diagnosed by autoantibody assays and metabolic tests during the prediabetic stage before onset of clinical diabetes. Thus, immune-intervention strategies aiming at the prevention of the overt disease become possible. Prophylactic therapies with nicotinamide and with insulin are currently tested in several studies. In this paper, preliminary results of the ongoing trials on insulin prophylaxis are presented. Also the future aspects of immune-intervention with T-cell-immunization are discussed.

Titel in Übersetzung	Type-1-diabetes - Possibilities of prevention
Originalsprache	Deutsch
Seiten (von - bis)	329-330
Seitenumfang	2
Fachzeitschrift	Sozialpadiatrie und Kinderarztliche Praxis
Jahrgang	17
Ausgabenummer	6
Publikationsstatus	Veröffentlicht - 1995

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gute Gesundheit und Wohlergehen

Schlagwörter

insulin autoantibodies
insulin prophylaxis
islet cell antibodies
pre-type-1-diabetes
prediction

Andere Dateien und Links

Verknüpfung zur Publikation in Scopus

Dieses zitieren

@article{85b27fc0152147c8b8c887281fea8f17,

title = "TYP-1-DIABETES - MOGLICHKEITEN DER PRAVENTION",

abstract = "Type-1-diabetes, being the end-result of an autoimmune disease, can today be diagnosed by autoantibody assays and metabolic tests during the prediabetic stage before onset of clinical diabetes. Thus, immune-intervention strategies aiming at the prevention of the overt disease become possible. Prophylactic therapies with nicotinamide and with insulin are currently tested in several studies. In this paper, preliminary results of the ongoing trials on insulin prophylaxis are presented. Also the future aspects of immune-intervention with T-cell-immunization are discussed.",

keywords = "insulin autoantibodies, insulin prophylaxis, islet cell antibodies, pre-type-1-diabetes, prediction",

author = "R. Schwertner and W. Rabl and Ziegler, \{A. G.\}",

year = "1995",

language = "Deutsch",

volume = "17",

pages = "329--330",

journal = "Sozialpadiatrie und Kinderarztliche Praxis",

issn = "0945-7712",

publisher = "Verlag Kirchheim and Co. GmbH",

number = "6",

}

TY - JOUR

T1 - TYP-1-DIABETES - MOGLICHKEITEN DER PRAVENTION

AU - Schwertner, R.

AU - Rabl, W.

AU - Ziegler, A. G.

PY - 1995

Y1 - 1995

N2 - Type-1-diabetes, being the end-result of an autoimmune disease, can today be diagnosed by autoantibody assays and metabolic tests during the prediabetic stage before onset of clinical diabetes. Thus, immune-intervention strategies aiming at the prevention of the overt disease become possible. Prophylactic therapies with nicotinamide and with insulin are currently tested in several studies. In this paper, preliminary results of the ongoing trials on insulin prophylaxis are presented. Also the future aspects of immune-intervention with T-cell-immunization are discussed.

AB - Type-1-diabetes, being the end-result of an autoimmune disease, can today be diagnosed by autoantibody assays and metabolic tests during the prediabetic stage before onset of clinical diabetes. Thus, immune-intervention strategies aiming at the prevention of the overt disease become possible. Prophylactic therapies with nicotinamide and with insulin are currently tested in several studies. In this paper, preliminary results of the ongoing trials on insulin prophylaxis are presented. Also the future aspects of immune-intervention with T-cell-immunization are discussed.

KW - insulin autoantibodies

KW - insulin prophylaxis

KW - islet cell antibodies

KW - pre-type-1-diabetes

KW - prediction

UR - https://www.scopus.com/pages/publications/0029037666

M3 - Kurzer Abriss

AN - SCOPUS:0029037666

SN - 0945-7712

VL - 17

SP - 329

EP - 330

JO - Sozialpadiatrie und Kinderarztliche Praxis

JF - Sozialpadiatrie und Kinderarztliche Praxis

IS - 6

ER -

TYP-1-DIABETES - MOGLICHKEITEN DER PRAVENTION

Abstract

UN SDGs

Schlagwörter

Andere Dateien und Links

Fingerprint

Dieses zitieren